Lantheus Holdings, Inc
Symbol: LNTH (NASDAQ)
Company Description:
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
- Today's Open: $56.72
- Today's High: $56.904
- Today's Low: $55.705
- Today's Volume: 651.62K
- Yesterday Close: $56.515
- Yesterday High: $57.43
- Yesterday Low: $56.29
- Yesterday Volume: 912.27K
- Last Min Volume: 0
- Last Min High: $55.829
- Last Min Low: $55.822
- Last Min VWAP: $0
- Name: Lantheus Holdings, Inc
- Website: https://www.lantheus.com
- Listed Date: 2015-06-25
- Location: NORTH BILLERICA, MA
- Market Status: Active
- CIK Number: 0001521036
- SIC Code: 2835
- SIC description: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Market Cap: $3.81B
- Round Lot: 100
- Outstanding Shares: 67.99M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-08-21 | 4 | View |
| 2025-08-21 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 3 | View |
| 2025-08-18 | 3 | View |
| 2025-08-18 | 3 | View |
| 2025-08-15 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 144 | View |
| 2025-08-11 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-22 | 8-K | View |
| 2025-07-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-13 | 144 | View |
| 2025-06-11 | 4 | View |
